Hudock, Inc. - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 37 filers reported holding SEELOS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Hudock, Inc. ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$010.0%0.00%
Q2 2022$010.0%0.00%
Q1 2022$010.0%0.00%
Q4 2021$010.0%0.00%
Q3 2021$010.0%0.00%
Q2 2021$010.0%0.00%
Q1 2021$010.0%0.00%
Q4 2020$010.0%0.00%
Q3 2020$010.0%0.00%
Q2 2020$010.0%0.00%
Q1 2020$010.0%0.00%
Q4 2019$010.0%0.00%
Q3 2019$010.0%0.00%
Q2 2019$010.0%0.00%
Q1 2019$010.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
PIPER SANDLER & CO. 164,778$361,0000.48%
Uniplan Investment Counsel, Inc. 692,623$1,516,0000.10%
ARDSLEY ADVISORY PARTNERS LP 50,000$110,0000.02%
A.R.T. Advisors, LLC 52,342$115,0000.01%
WEDBUSH SECURITIES INC 16,000$35,0000.00%
WealthPLAN Partners, LLC 10,000$17,0000.00%
Renaissance Technologies 929,465$2,036,0000.00%
Squarepoint Ops LLC 28,629$63,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 17$00.00%
View complete list of SEELOS THERAPEUTICS INC shareholders